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Transmissible spongiform encephalopathy
TSEencephalopathies (TSEs) are fatal neurodegenerative diseases that include
Creutzfeldt–Jakob disease, bovine spongiform encephalopathy and sheep scrapie. Although one of the
earliest events during TSE infection is the cellular uptake of protease resistant prion protein (PrP-res), this
process is poorly understood due to the difﬁculty of clearly distinguishing input PrP-res from either PrP-res
or protease-sensitive PrP (PrP-sen) made by the cell. Using PrP-res tagged with a unique antibody epitope,
we examined PrP-res uptake in neuronal and ﬁbroblast cells exposed to three different mouse scrapie strains.
PrP-res uptake was rapid and independent of scrapie strain, cell type, or cellular PrP expression, but occurred
in only a subset of cells and was inﬂuenced by PrP-res preparation and aggregate size. Our results suggest
that PrP-res aggregate size, the PrP-res microenvironment, and/or host cell-speciﬁc factors can all inﬂuence
whether or not a cell takes up PrP-res following exposure to TSE infectivity.
© 2008 Elsevier Inc. All rights reserved.IntroductionTransmissible spongiform encephalopathies (TSEs) are fatal neu-
rodegenerative diseases that include kuru, Creutzfeldt–Jakob disease,
and Gerstmann–Sträussler–Scheinker syndrome in humans as well as
bovine spongiform encephalopathy, sheep scrapie, and chronic
wasting disease (CWD) in deer and elk (Priola and Vorberg, 2006).
Partially protease resistant prion protein (PrP-res) associates closely
with infectivity and is considered to be a marker of TSE infection. PrP-
res is derived from the normal protease-sensitive form of PrP, PrP-sen.
The post-translational, conformationally driven conversion of PrP-sen
to PrP-res is a critical, though poorly understood, event during TSE
pathogenesis.
Certain cell types when exposed to scrapie-infected brain homo-
genate will produce PrP-res over multiple serial passes, and when
injected into experimental animals, cause disease. These cells are
considered to be persistently infected. A number of studies have
shown that both neuronal and non-neuronal cell lines can become
persistently infected with certain strains of mouse scrapie, sheep
scrapie or CWD (Baron et al., 2006; Butler et al., 1988; Race et al., 1987;l rights reserved.Raymond et al., 2006; Rubenstein et al., 1984; Schatzl et al., 1997;
Vorberg et al., 2004a; Vorberg et al., 2004b). The vast majority of what
is understood about the process of cell infection and PrP-res formation
has been the result of studies on such persistently infected cells. These
studies have shown that PrP-res formation in infected cells occurs at
the cell surface and/or along the endocytic pathway (Beranger et al.,
2002; Borchelt et al., 1992; Caughey and Raymond,1991) and that cell-
associated PrP-res has a long half life (Borchelt et al., 1990; Caughey
and Raymond, 1991) and can accumulate in endolysosomal compart-
ments (Caughey et al., 1991; McKinley et al., 1991; Pimpinelli et al.,
2005; Taraboulos et al., 1994). Although cells persistently infected
with scrapie agent have provided important insights into the cellular
biology of PrP-res formation during infection, very little is known
about how PrP-res is initially taken up by cells.
Several recent studies have looked at the earlier stages of TSE
infection with some data suggesting that PrP-res is taken up rapidly
(i.e. within 24 h) (Hijazi et al., 2005; Horonchik et al., 2005; Mohan
et al., 2005; Paquet et al., 2007) and other data indicating that uptake
may occur more slowly (i.e. over days) (Bergstrom et al., 2006;
Magalhaes et al., 2005). Most of these earlier studies were limited by
the difﬁculty of speciﬁcally distinguishing PrP-res in the inoculum
from PrP-res newly made in the cells which may help to explain the
conﬂicting results. Even in instances where partially puriﬁed PrP-res
Fig. 2.Mouse neural cells take up PrP-res3F4. Western blot analysis of PrP-res3F4 uptake
into MoL42-CFD5 cells. Brain homogenate from 22L, ME7 or Obihiro scrapie-infected Tg
(WT-E1) mice was PK-treated and used as positive controls (panels A–C, lane 2) while
PK-treated brain homogenate from mock-infected Tg(WT-E1) mice was used as
negative controls (panels A–C, lane 1). For both the positive and negative controls,
1/20th of the total homogenate used was loaded onto the gel. Brain homogenates
(200 μl of a 1% brain homogenate) from 22L(3F4) (panel A), ME7(3F4) (panel B), or Obi
(3F4) (panel C) were added to MoL42-CFD5 cells for 24 h and then removed from the
cell monolayer. Cell debris and dead cells were spun out of the supernatant and the
supernatant pellet was PK-treated, methanol precipitated and the entire sample loaded
onto the gel (SN Pellet). Cells were then rinsed with PBS four times (rinse 1–4), lysed,
and both the cell lysate and rinses were PK-treated, methanol precipitated and the
entire sample loaded onto the gel. PrP-res3F4 was detected in the lysed and PK-treated
cells (Cells). All blots were analyzed using the mouse monoclonal antibody 3F4 and
developed using ECL (Amersham). The percentage of total PrP-res3F4 taken up by the
cells after 24 h is shown in panel D. PrP-res3F4 was quantiﬁed as detailed in theMaterials
and methods. There was no signiﬁcant difference between the three strains in the
285C.S. Greil et al. / Virology 379 (2008) 284–293was uniquely labeled, it was not always possible to absolutely
distinguish the labeled PrP-res from other labeled, but non-relevant,
protein contaminants (Magalhaes et al., 2005). Additionally, few
studies have examined more then one strain of TSE agent meaning
that any potential differences in strain-speciﬁc PrP-res uptake early
during infection remain largely unresolved.
Using uniquely epitope tagged PrP-sen molecules we have
previously shown that, regardless of scrapie strain, both mouse
neuroblastoma (MNB) cells as well as mouse ﬁbroblast cells form de
novo PrP-res after only 4 h of scrapie exposure (Vorberg et al., 2004a).
This ﬁnding strongly suggests that the association of PrP-res with a
cell occurs rapidly. We have now used PrP-res uniquely taggedwith an
epitope to the mouse monoclonal antibody 3F4 to examine the
interactions between PrP-res from different strains of mouse scrapie
and different cell types during the acute stage of scrapie infection
(0–72 h). Our results show that PrP-res uptake is indeed very rapid
and independent of cell type, scrapie strain, and host cell PrP-sen
expression. However, PrP-res uptake was inﬂuenced by PrP-res
aggregate size and only a certain subpopulation of cells detectably
internalized PrP-res. Furthermore, PrP-res in brain homogenate was
taken up more efﬁciently by cells then either partially puriﬁed PrP-res
or PrP-res in brain microsomes. Our results suggest that, while PrP-res
uptake during acute infection appears to be similar for different
scrapie strains and cell types, internalization of PrP-res can be
inﬂuenced by PrP-res aggregate size, PrP-res microenvironment,
and/or an as yet unidentiﬁed host factor or factors.
Results
PrP-res3F4 uptake by mouse neural cells
To determine whether or not our mouse neural cells were able to
take up PrP-res3F4, MoL42-CFD5 cells were exposed to 22L(3F4), ME7
(3F4), Obi(3F4) or uninfected Mock(3F4) brain homogenates. MoL42-
CFD5 cells are mouse neuronal PrP0/0 cells that have been modiﬁed to
express mouse PrP-sen that is recognized by the mouse monoclonal
antibody L42 allowing us to distinguish it, if necessary, from mouse
PrP in the brain homogenate. MoL42 PrP-sen is not recognized by the
3F4 mouse monoclonal antibody (Fig. 1).
After 24 h incubation time, cells were rinsed to remove any
unbound PrP-res3F4, lysed and assayed for PrP-res3F4 by Western
blot as shown in Fig. 2. Unbound, excess PrP-res3F4 was effectively
washed from the cells by four rinses of fresh media (Figs. 2A–C) and
no PrP-res3F4 could be detected in cells exposed to Mock(3F4) brain
homogenate (Figs. 2A–C, lane 1). Thus, residual, unbound PrP3F4
could be efﬁciently removed from the cell monolayer. PrP-res3F4
associated with detached cells, cell debris, and/or unbound brainFig. 1. Cell line expression of PrP. Western blot detection of PrP-sen with either mouse
monoclonal antibody 3F4 (left panel) or mouse monoclonal antibody L42 (right panel)
for cell lines CF10 (lanes 1, 5), MoL42-CFD5 (lanes 2, 6), andMoL42-Ψ2A2 (lanes 3, 7). As
a positive control for the speciﬁcity of the 3F4 antibody, lane 4 shows CF10 cells
expressing Mo3F4.
amount of PrP-res taken up by the MoL42-CFD5 cells (pN0.05 using 1-way ANOVAwith
Bonferroni's multiple comparison test). Data are shown as mean±S.D. for N=12.homogenate was observed in the pellet from a low speed spin of the
cellular supernatant (Figs. 2A–C, SN pellet) but signiﬁcant amounts
remained cell-associated (Figs. 2A–C, Cells). By 24 h, the amount of
PrP-res3F4 that was cell-associated was 10–15% of the total PrP-res
added to the cells (Fig. 2D), a percentage that did not signiﬁcantly
change at later time points (Fig. 4 and data not shown). Thus,
unbound PrP-res3F4 (i.e. PrP-res3F4 in both the SN pellet and the
clariﬁed supernatant) remained in excess throughout the course of
the experiment. These data suggest that the majority of PrP-res3F4 in
the brain homogenate did not interact with the cells.
PrP-res is internalized by cells
To determine if cell-associated PrP-res3F4 was bound to the cells
non-speciﬁcally or internalized via an active cellular process such as
endocytosis, MoL42-CFD5 cells were exposed to scrapie-infected brain
Fig. 3. PrP-res3F4 uptake into neural cells is signiﬁcantly decreased at 18 °C. MoL42-CFD5 cells were exposed to infected brain homogenate from 22L(3F4), ME7(3F4) or Obi(3F4)
scrapie for 24 h at either 37 °C or 18 °C. Samples were PNGaseF treated to remove complex glycans. Non-PK-digested infected brain homogenates were run to illustrate total PrP levels
(lanes 1, 7, 13) while PK-digested brain homogenates were run as a positive control for PrP-res (lanes 2, 8, 14). Some PrP-sen3F4 was taken up by cells at 37 °C (−PK lanes 3, 9, 15) and
PrP-res3F4 was detected in cells which had been exposed to scrapie brain homogenate and incubated at 37 °C (+PK lanes 4, 10, 16). Exposure time for panel A was 8 min. After
overnight exposures of the gels, some PrP-sen3F4 (−PK lanes 5, 11, 17) and a low level of PrP-res3F4 (+PK lanes 6, 12, 18) were detected in cells which had been exposed to scrapie brain
homogenate and incubated at 18 °C (panel B). All blots were analyzed using the mouse monoclonal antibody 3F4 and developed using ECL (Amersham).
Fig. 4. Kinetics of PrP-res3F4 uptake into cells. (A) Representative Western blot analysis of PrP-res3F4 uptake into MoL42-CFD5 cells from 0–72 h. Scrapie-infected brain homogenates
from 22L(3F4), ME7(3F4) or Obi(3F4) were analyzed. The ﬁrst three lanes of each gel show PK-treated scrapie-infected brain homogenate for the appropriate strain loaded in 20 μl,
10 μl, and 5 μl volumes. These lanes were used as internal standards to establish a constant ﬁlm exposure time from experiment to experiment (4 min) in order to quantify the data
within the linear range of the ﬁlm. The amount of PrP-res internalized by the cells increased over time. (B) Graphical representation of total cell-associated 22L(3F4), ME7(3F4), or Obi
(3F4) taken up by either MoL42-CFD5 cells (solid lines N=5 or 6) or CF10 cells (dotted lines N=3) from 0–72 h. The error bars represent SEM. No statistically signiﬁcant differences
were found between the scrapie strains (pN0.05, 2-way ANOVA) or between the different cell types (pN0.05,Mann Whitney test) for each scrapie strain. (C) Graphical representation
of total cell-associated 22L, ME7 or Obihiro PrP-res3F4 taken up by MoL42-ψ2A2 ﬁbroblast cells (N=3) from 0–72 h where the error bars represent SEM. No statistically signiﬁcant
differences were found between the scrapie strains (pN0.05, 2-way ANOVA) or between the ﬁbroblast and neuronal cell types (pN0.05, Mann Whitney test). All blots were analyzed
using the mouse monoclonal antibody 3F4. For all data, the amount of PrP-res is expressed in pixels and was quantiﬁed by analysis of ECL developed western blots using the UN-
SCAN-IT software as detailed in the Methods.
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Fig. 5. Increased levels of cellular PrP-res3F4 correlate with increased cell number. Ratio
of total cell number to total cell-associated PrP-res3F4 for scrapie strains 22L(3F4), ME7
(3F4) or Obi(3F4). PrP-res3F4 was quantiﬁed using ECL developed western blots
analyzed with the UN-SCAN-IT software. (A) Ratio of the number of MoL42-CFD5 cells
to total PrP-res3F4 (N=5). (B) Ratio of the number of CF10 cells to total PrP-res3F4 (N=6).
(C) Ratio of the number of MoL42-ψ2A2 cells to total PrP-res3F4 (N=6). The variability of
the data at later time points was likely due to increased cell death over time (data not
shown) rather than any cell-type differences.
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or at 37 °C. Without PK digestion, some PrP3F4 was bound and/or
internalized in the cells at both 37 and 18 °C (Fig. 3A), although in the
case of 22L(3F4) a longer gel exposure was required to detect it (Fig.
3B). This material was also observed when uninfected brain homo-
genate was overlayed onto the cells (data not shown) suggesting that
at least some fraction of the PrP-sen3F4 in the brain homogenate was
aggregated and interacting with the cells. As shown in Fig. 3A, cells
exposed to scrapie-infected brain homogenates at 37 °C were positive
for PrP-res3F4 while cells which were exposed to scrapie-infected
brain homogenates at 18 °C appeared to be negative for PrP-res3F4.
However, upon longer exposure of the gel, it was clear that a small
amount of PrP-res3F4 was also cell-associated at 18 °C (Fig. 3B). Given
the fact that very long gel exposures were required to reliably detect
PrP-res3F4 associated with cells at 18 °C, our data suggest that the
majority of the cell-associated PrP3F4 is likely being actively
internalized by the cells and not simply attaching to the cell surface.
Rapid PrP-res3F4 uptake into cells is independent of scrapie strain, cell
type and host cell PrP-sen expression
In order to determine the kinetics of PrP-res3F4 uptake into cells
during exposure to TSE infectivity, MoL42-CFD5 cells were exposed to
PrP-res3F4 in 22L, ME7, or Obihiro scrapie-infected brain homogenates
for 0–72 h. For each strain, cell-associated PrP-res3F4 was detected by
2 h post-exposure and the amount of PrP-res3F4 internalized by the
cell increased over time (Fig. 4A). Quantiﬁcation of total PrP-res3F4
uptake into the cells for each given time point showed that there were
no signiﬁcant differences in PrP-res3F4 uptake amongst the different
scrapie strains. For each strain, approximately half of the total PrP-res3F4
eventually taken up by the cells was cell-associated by 10–15 h
post-inoculation and the majority was taken up by 24 h. Although
ME7 appeared to be taken up more slowly by MoL42-CFD5 cells (Fig.
4B, ME7 solid line), this difference was not statistically signiﬁcant
when compared to the other strains (pN0.05 by 2-way ANOVA).
Previous studies have suggested that cells exposed to scrapie
associate with PrP-res independently of host cell PrP expression
(Hijazi et al., 2005; Paquet et al., 2007). However, given that both the
rabbit epithelial cells expressing doxycyline inducible sheep PrP-sen
(Rov cells) (Paquet et al., 2007) and the Chinese hamster ovary (CHO)
cells (Hijazi et al., 2005) used in these studies may still express low
levels of PrP-sen (Hijazi et al., 2005), a role for PrP-sen in PrP-res
uptake could not be completely ruled out. To determine whether or
not host cell PrP-sen expression was needed for the internalization of
PrP-res, we utilized a cell line (CF10) derived from PrP0/0 mice. CF10
cells are neural cells and are the parent cell line of MoL42-CFD5 cells.
However, CF10 cells do not express PrP-sen (Fig. 1). PrP-res3F4 was
taken up by the CF10 cells similarly to MoL42-CFD5 cells (Fig. 4B,
dashed lines). Thus, the uptake of PrP-res derived from different
strains of mouse scrapie is independent of PrP-sen expression by the
host cell.
We next determined if cell type could inﬂuence PrP-res uptake into
cells. To test this, non-neuronal MoL42-ψ2A2 cells (a ﬁbroblast cell
line) were analyzed using the same kinetics assay employed on both
the MoL42-CFD5 and CF10 cell lines. Results from this assay showed
that, for all strains tested, the MoL42-ψ2A2 cells took up PrP-res3F4
from scrapie brain homogenate similarly to either MoL42-CFD5 or
CF10 cells (Fig. 4C). Thus, the kinetics of PrP-res uptake were similar
for both neuronal and non-neuronal cell types, at least with respect to
ﬁbroblast cells.
Increased PrP-res uptake correlates with increased cell number
The observed increase in cell-associated PrP-res3F4 over 72 h could
be due either to an increase in the number of cells harboring PrP-
res3F4 or to an increase in the amount of PrP-res3F4 per cell. To
288 C.S. Greil et al. / Virology 379 (2008) 284–293determine if increased PrP-res3F4 uptake correlated with cell number,
the number of cells at each time point was divided by the amount of
PrP-res3F4 taken up by the cells as quantiﬁed by Western blot. This
ratio of cell number to cell-associated PrP-res3F4 was then plotted
against the time cell cultures were exposed to scrapie brain
homogenate. For all strains and cell lines tested, the ratio of cells to
total PrP-res3F4 was high 2 h after exposure of the cells to the infected
homogenate. However, over time that ratio decreased and, as
indicated by the linear portion of the curve, after 8 h was essentially
1:1 (Figs. 5A–C). These data suggest that the system had reached a
saturation point and that the population of cells within the culture
that could take up PrP-res was limited (Figs. 5A–C).
In order to determine if the number of PrP-res3F4 positive cells
increased over time, the uptake of partially puriﬁed PrP-res3F4 into
MoL42-CFD5 cells was assessed by immunoﬂuorescentmicroscopy for
22L(3F4), ME7(3F4) and Obi(3F4) PrP-res3F4. Similar to the westernFig. 6. PrP-res3F4 uptake into neural cells using immunoﬂuorescence microscopy. PrP-res3F4
added to MoL42-CFD5 cells for 2–48 h. Cells were rinsed, ﬁxed and immunolabeled with the
detect PrP-res3F4 while DAPI stain (blue) denotes cell nuclei. All images were taken with a 4blot data in Fig. 4, cell-associated PrP-res3F4 was detected as early as
2 h. PrP-res3F4 was observed as small, punctate aggregates generally
localized to both cytoplasmic and perinuclear regions (Fig. 6).
Consistent with the data in Fig. 5, as cell numbers increased so too
did the number of cells positive for PrP-res3F4. However, for all time
points examined, only 30–40% of the cells were positive for PrP-res3F4.
Our results suggest that there is a select subpopulation of cells able to
take up PrP-res which, over time, divide and increase in number
leading to the observed increase in the amount of cell-associated
PrP-res.
PrP-res aggregate size inﬂuences PrP-res binding and uptake
Uptake of PrP-res3F4 in cells in our assay was quite different from
that of previous studies where large, ﬂuorescent PrP-res aggregates
were not fully internalized by SN56 neuronal cells until several dayspartially puriﬁed from 22L(3F4), ME7(3F4), Obi(3F4) or mock brain homogenates was
mouse monoclonal antibody 3F4. Anti-mouse FITC labeled antibody (green) was used to
0× objective.
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test whether differences in cell type or PrP-res preparation could
account for these discrepancies, we exposed differentiated SN56
neuronal cells for 24 h to either 22L PrP-res3F4 or 22L PrP-res3F4
conjugated to an Alexa-Fluor-596 ﬂuorescent tag (Fig. 7). SN56 cells
exposed to Alexa-Fluor labeled 22L PrP-res3F4 showed very large
PrP-res3F4 aggregates (Fig. 7A) that were indistinguishable from those
described previously (Baron et al., 2006; Magalhaes et al., 2005). By
contrast, SN56 cells exposed to non-Alexa-Fluor labeled 22L PrP-res3F4
(Fig. 7B) showed the same small, punctate aggregates of PrP-res3F4
observed in MoL42-CFD5 cells (Fig. 6). When both Alexa-Fluor labeled
PrP-res from 22L scrapie-infected wild typemice and non-Alexa-Fluor
labeled 22L PrP-res3F4 were added to the same monolayer of SN56
cells, the difference in PrP-res aggregate size was even more apparent
(Fig. 7C). The difference in aggregate size between 22L PrP-res and
Alexa-Fluor labeled 22L PrP-res strongly suggests that the larger
PrP-res aggregates were primarily a consequence of the Alexa-Fluor
labeling process.
When both Alexa-Fluor labeled 22L PrP-res from scrapie-infected
wild type mice and non-Alexa-Fluor labeled 22L PrP-res3F4 were
added to the same monolayer of SN56 cells, there was almost no co-
localization between the PrP-res molecules in the two preparations
(Fig. 7C). To help resolve this difference in co-localization, we
conducted a temperature shift analysis of SN56 cells exposed to
both Alexa-Fluor labeled 22L PrP-res from wild type mice and non-
Alexa-Fluor labeled PrP-res3F4 (Fig. 7D). Cells incubated at 37 °C (Fig.Fig. 7. Large PrP-res aggregates bind to the cell surface and are not rapidly internalized. Differ
22L PrP-res3F4 for 24 h. Cells were then rinsed, ﬁxed and when necessary, immunolabeled wi
(green) was used to detect 22L PrP-res3F4, while DAPI stain (blue) denotes cell nuclei. Alexa-F
exposed to (A) Alexa-Fluor labeled partially puriﬁed 22L PrP-res3F4 (red), (B) partially puriﬁ
scrapie-infected wild typemouse (red) and partially puriﬁed 22L PrP-res3F4 (green) (inset tak
Alexa-Fluor labeled partially puriﬁed PrP-res from a 22L scrapie-infected wild type mouse (r
colocalize with the smaller, more punctate PrP-res3F4 aggregates.7D) showed localization patterns similar to Fig. 7C. However, cell-
associated PrP-res3F4 was not detected at 18 °C suggesting that the
amount of PrP-res3F4 bound or internalized by the cells at was very
low (Fig. 7D). By contrast, signiﬁcant amounts of Alexa-Fluor labeled
PrP-res were cell-associated at 18 °C (Fig. 7D) suggesting that it was
bound to the cell surface via either PrP-res3F4 or the Alexa-Flour dye
moiety. The fact that Alexa-Fluor labeled PrP-res was largely out of the
plane of focus of the cell when examined by immunoﬂuorescence
(note the faint halo effect around the red Alexa-Fluor labeled PrP-res
aggregates in Fig. 7) also supports the conclusion that these
aggregates were primarily localized at the cell surface. Our data
suggest that during the ﬁrst 24 h of infection, large PrP-res aggregates
are localized primarily at the cell surface while smaller aggregates are
rapidly internalized.
Infectious brain homogenate PrP-res is taken up most efﬁciently by cells
A number of PrP-res preparation methods have been employed to
infect cells in vitro (Baron et al., 2006; Baron et al., 2002; Bendheim et
al., 1984; Vorberg and Priola, 2002). To test if different PrP-res
preparation methods would alter PrP-res uptake into cells, equal
amounts of Obihiro PrP-res3F4 derived either from partially puriﬁed
PrP-res or infectious crude brain homogenate were added to MoL42-
CFD5 cells and the uptake of PrP-res into the cells was assayed by
Western blot. By 8 h post infection, infectious crude brain homogenate
appeared to be taken up signiﬁcantly more efﬁciently then partiallyentiated SN56 cells were exposed to Alexa-Fluor-596 labeled (red) or unlabeled (green)
th the mouse monoclonal antibody 3F4 (panels B–D). Anti-mouse FITC labeled antibody
luor-596 labeled proteins are red. All images were takenwith a 40× objective. Cells were
ed 22L PrP-res3F4 (green), (C) Alexa-Fluor labeled partially puriﬁed PrP-res from a 22L
enwith a 60× objective). In panel D, cells were exposed for 24 h at either 18 °C or 37 °C to
ed) and 22L PrP-res3F4 (green). The larger Alexa-Fluor labeled PrP-res aggregates do not
Fig. 8. Infectious brain homogenate PrP-res3F4 is taken up more efﬁciently then either
microsome or partially puriﬁed PrP-res3F4. Graphical representation of PrP-res3F4
uptake from 0–24 h into MoL42-CFD5 cells (N=6) where error bars represent SEM. (A)
Kinetics of PrP-res3F4 uptake using either infectious brain homogenate PrP-res3F4 (BH-I),
partially puriﬁed PrP-res3F4 (PrP-res3F4) or partially puriﬁed PrP-res3F4 with mock-
infected brain homogenate (PrP-res3F4+BH-M) added tomatch the total protein content
of BH-I (⁎pb0.05, t=8–24 h, Bonferroni's test). (B) Kinetics of PrP-res3F4 uptake using
either infectious microsome PrP-res3F4 (Microsome-I), puriﬁed PrP-res3F4 (PrP-res3F4) or
partially puriﬁed PrP-res3F4 with mock-infected microsomes (PrP-res3F4+Microsome-
M) added to match total protein content of infectious microsomes (pN0.05 for all time
points, Bonferroni's test). All data was obtained with IR-dye 800CW developed western
blots where the PrP-res3F4 level was quantiﬁed as ﬂuorescent units using the Li-Cor
Odyssey imaging system and associated software.
290 C.S. Greil et al. / Virology 379 (2008) 284–293puriﬁed PrP-res (Fig. 8A, open triangles). To determine whether or not
this discrepancy in PrP-res uptake was due to a difference in total
protein, mock-infected brain homogenate was added to the partially
puriﬁed PrP-res in order to match the total protein content found in
the infectious brain homogenate. Protein adjusted partially puriﬁed
PrP-res was taken up with the same efﬁciency as partially puriﬁed
PrP-res alone (Fig. 8A). Microsome PrP-res was also taken up by cells
with the same efﬁciency as either partially puriﬁed PrP-res or total
protein adjusted partially puriﬁed PrP-res (total protein adjusted with
mock-infected microsome preparation) (Fig. 8B). Taken together, our
results suggest that there is an increased efﬁciency in the uptake of
PrP-res when it is associated with an infectious brain homogenate.
Discussion
The use of PrP-res tagged with a unique antibody epitope has
allowed us to examine for the ﬁrst time the cellular uptake of PrP-respresent in an infectious inoculum in the absence of any confounding
background from host cell derived PrP-res or PrP-sen. Our data show
that PrP-res uptake is cell type and scrapie-strain independent and are
consistent with previous work where the acute conversion of cellular
PrP-sen to PrP-res was also found to be cell type and scrapie-strain
independent (Vorberg et al., 2004a). Furthermore, the current study
demonstrates that during the ﬁrst 3 days post-scrapie exposure cells
take up PrP-res from different strains at a similar rate (Figs. 4 and 6)
and that this process absolutely does not require host cell expression
of PrP-sen (Fig. 4). Thus, although PrP-sen is necessary for persistent
PrP-res formation and scrapie infection, its absence in cells does not
inhibit acute uptake of PrP-res.
Regardless of strain, PrP-res uptake into cells was detectable by
2 h (Figs. 4 and 6) and, after 8 h, was apparently restricted by total
cell number (Fig. 5). This change in the kinetics curve may be related
to the fact that most cells are still rapidly dividing and in log phase
during the ﬁrst 8 h of exposure to PrP-res. Over time, the cells
become more conﬂuent and PrP-res uptake may be reduced as
cellular division slows. This interpretation is consistent with the
recent observation that cell division can also inﬂuence PrP-res levels
within mouse neuroblastoma cells persistently infected with scrapie
(Ghaemmaghami et al., 2007).
For all mouse strains tested, our results show that 10–15% of
PrP-res3F4 in the brain homogenate was taken up by the cells (Fig. 2D).
This is in stark contrast to a recent study showing that the amount of
PrP-res taken up by the cell during acute TSE infection was strain
dependent and could exceed 80% (Paquet et al., 2007). One possible
explanation for this discrepancy is that the population of cells
susceptible to TSE infection is higher in the epithelial cells used in the
previous study than in the cells used here. Another possibility is that
strain-speciﬁc differences in the size of the PrP-res aggregate may
inﬂuence how much PrP-res the cells take up. The recent observation
that PrP-res particle size can inﬂuence scrapie infectivity (Silveira et
al., 2005), the demonstration that large Alexa-Fluor PrP-res aggre-
gates are broken down over several days into smaller aggregates
which are then internalized by the cell (Magalhaes et al., 2005), as
well as our data demonstrating that large Alexa-Fluor-labeled PrP-res
aggregates are not rapidly internalized (Fig. 7A), are all consistent
with this possibility.
Interestingly, at any given time point only 30–40% of the cells
were able to take up detectable levels of PrP-res (Fig. 6) despite the
fact that it was always supplied in excess. The most likely explanation
for this result is that there is a limited population of cells which can
detectably take up PrP-res. Over time, these cells divide and increase
in number leading to the observed increase in the amount of cell-
associated PrP-res, a process that may also be important once
persistent infection has been established (Ghaemmaghami et al.,
2007; Weissmann, 2004). Alternatively, it may be that only certain
cells have the necessary cell surface ligands to endocytose PrP-res. A
third possibility may relate to the observation that the pathway of
cellular internalization of particles such as viruses and bacteria is
inﬂuenced by both particle size and the composition of plasma
membrane microdomains (Cheng et al., 2006) Perhaps only a certain
subpopulation of cells within the culture have the plasma membrane
microdomains needed to efﬁciently interact with and internalize
PrP-res. Whatever the explanation, our data are consistent with the
hypothesis that PrP-res aggregate size can inﬂuence not only how
PrP-res initially interacts with the cell but also its uptake.
Mouse PrP-res from all strains tested formed small, punctate
aggregates that appeared to localize primarily in the perinuclear and
cytoplasmic regions of the cell (Fig. 6). This localization is consistent
with earlier studies of PrP-res in persistently infected cells (Caughey et
al., 1991;McKinley et al., 1991; Pimpinelli et al., 2005; Taraboulos et al.,
1994) and these punctate aggregates likely act as PrP-res seeds that
help propagate new PrP-res formation (Vorberg et al., 2004a). Despite
the evidence that cell type can inﬂuence establishment of a persistent
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were unable to detect any differences in the cellular localization of
PrP-res. For example, both ME7 and 22L PrP-res appeared to be in
similar cytoplasmic and perinuclear locations (Fig. 6), despite the fact
that the 22L scrapie strain infects ﬁbroblast cells while ME7 does not
(Vorberg et al., 2004a). This suggests that the initial cellular location of
the inoculum PrP-res may not be a determining factor in whether or
not a cell becomes persistently infected. However, given the fact that
our current results do not allow us to clearly distinguish different
cellular compartments, further studies looking at the co-localization
of input PrP-res3F4 with different cellular markers will be needed to
determine if this is the case.
Previous studies using the hamster scrapie strain 263K and CHO
cells found that hamster PrP-res remained cell-associated at 18 °C and
likely bound to cells via cell surface heparan sulfate (Hijazi et al.,
2005). It was therefore somewhat surprising that we found that only a
small amount of mouse PrP-res3F4 was cell-associated at 18 °C (Figs. 3
and 7D). Our data comparing Alexa-Fluor labeled PrP-res to unlabeled
PrP-res demonstrate that PrP-res aggregate size can inﬂuence
whether or not PrP-res can detectably bind to the cell surface. Thus,
one explanation for the difference between the mouse and hamster
results could be that hamster PrP-res aggregates are larger than
mouse PrP-res aggregates. Alternatively, it is possible that at 18 °C the
receptor for internalization of mouse PrP-res is largely absent from the
cell surface but still present for hamster PrP-res. However, the low
level of mouse PrP-res cell surface binding and uptake at 18 °C (Figs. 3
and 7D) suggests that mouse PrP-res is taken up into cells through an
active cellular process such as endocytosis that may not necessarily be
mediated by a speciﬁc cell surface ligand.
PrP-res within an infectious brain homogenate was taken up
more efﬁciently then either partially puriﬁed PrP-res or PrP-res in
microsome preparations (Fig. 8). This suggests that there may be a
co-factor or some type of PrP-res associated microenvironment that
is speciﬁc to infectious brain homogenate which is removed or
disrupted during either of the alternative PrP-res preparations.
Consistent with the idea that PrP-res may have to be in a speciﬁc
microenvironment to efﬁciently infect cells (Baron et al., 2006), the
simple addition of brain homogenate protein to partially puriﬁed
PrP-res preparations did not enhance the uptake of partially puriﬁed
PrP-res (Fig. 8A). It is also unlikely that microsomes provide the ap-
propriate microenvironment given that microsome PrP-res was not
taken up as efﬁciently as PrP-res in brain homogenate (Fig. 8B). Our
results do not negate the possibility that microsomes may be more
infectious (Baron et al., 2006), but suggest that the apparent increased
efﬁciency with which microsomes infect cells is not due to more
efﬁcient uptake of PrP-res during the early stages of infection as
previously proposed (Baron et al., 2006).
In combinationwith earlier studies (Vorberg et al., 2004a), our data
suggest that there may be at least two blocks to the persistent
infection of a cell with scrapie. The ﬁrst occurs during the acute stage
of infection (0–72 h) when factors such as PrP-res aggregate size, the
microenvironment of the PrP-res inoculum, and/or the presence of a
speciﬁc population of cells help to determinewhether or not PrP-res is
bound to the cell and internalized. This block would not be strictly
dependent upon scrapie strain or cell type but rather would depend
upon heterogeneity in both the PrP-res and cell populations. Once a
cell culture becomes persistently infected, cellular heterogeneity may
also inﬂuence both the level and stability of infectivity over long term
passage (Bosque and Prusiner, 2000; Enari et al., 2001; Weissmann,
2004).
We have previously shown that the mouseΨ2 ﬁbroblast cells used
in the present study can be infected with the 22L, but not the ME7,
strain of mouse scrapie (Vorberg et al., 2004a). The fact that ME7 acts
similarly to 22L during acute infection (Figs. 4 and 5 and Vorberg et al.,
2004a) suggests that the second block to infection is scrapie-strain
dependent and occurs 1) after uptake and localization of the inoculumPrP-res and, 2) after an acute burst of new PrP-res formation in the cell
(Vorberg et al., 2004a).
Materials and methods
PrP0/0 neural cell line
Pregnant mice in which the PRNP gene has been knocked out
(PrP0/0) (Manson et al., 1994) were anesthetized with isoﬂuorane at
gestation day 15. Embryos were isolated, decapitated and the heads
were transferred to cold dissecting solution (phosphate buffered
saline (PBS), Ca2+/Mg2+ free, 5% glucose). Brains were removed and
freed of meninges and blood vessels, cut into 5 mm2 pieces, and
disassociated by aspiration in Dulbecco's phosphate buffered saline
(DPBS) with 10% FBS (Gibco Inc.), 0.5 mM glutamine, and B27. The
cell suspension was centrifuged at 160 ×g, 4 °C, 5 min and cells were
resuspended in DMEM with 5% FBS, and F12. Cells were adjusted
such that 40,000 cells/well were plated on poly-L-lysine coated 24
well plates. After 4 h incubation at 37 °C, 5% CO2, medium was
replaced with 1 ml/well of DMEM with growth supplements FBS
(3%), B27, and N2. Transfection of cells for immortalization was done
48 h after plating, using the plasmid vector pSV3-neo (ATCC, #37150)
(Southern and Berg, 1982) and lipofectamine (Invitrogen) according
to the manufacturer's instructions. Two days after transfection, G418
was added to the medium to select for transfected, immortalized
cells. Immortalized clones were pooled and single cell clones were
established. A single cell clone (CF10) was selected and maintained in
Opti-MEM supplemented with 10% FBS and 1% penicillin streptomy-
cin (PS). CF10 cells are strongly positive for nestin (data not shown)
which is predominantly found in stem cells of the CNS. Therefore, it
is likely that they are neural stem cells.
MoL42-CFD5 and Mo3F4-CF10 cell lines were derived by limiting
dilution cloning from CF10 cells that had been transduced with a
retrovirus encoding the mutant PrP molecule of interest (Mann et al.,
1983). The Mo3F4-CF10 cells express mouse PrP with the epitope to
the mouse monoclonal antibody 3F4 (Mo3F4), while the MoL42-CFD5
cells express mouse PrP with the epitope to the mouse monoclonal
antibody L42 (MoL42) (Vorberg et al., 1999). The L42 epitope can be
used to distinguish mouse PrP in the cells from mouse PrP in brain
homogenate.
Fibroblast cells (ψ2) are susceptible to infection with the mouse
scrapie strain 22L but not with the ME7 strain (Vorberg et al., 2004a).
MoL42-ψ2A2 is a cell line derived by limiting dilution cloning from
ψ2 ﬁbroblast cells (Mann et al., 1983; Miller and Buttimore, 1986)
that had been transduced by the same retrovirus used to make the
MoL42-CFD5 cells. MoL42-ψ2A2 cells express both endogenous
mouse PrP as well as mouse PrP with the L42 epitope. MoL42-
ψ2A2 cells were maintained in RPMI with 10% FBS supplemented
with 1% penicillin/streptomycin (ﬁnal concentration of 100 U/ml
penicillin G and 100 μg/ml streptomycin) (Invitrogen). SN56 cells are
neuronal derived cells from mouse septum neurons (Hammond et al.,
1990) and were used with the kind permission of Dr. Bruce Wainer
(Department of Pathology, Emory University of Medicine, Atlanta, GA).
PrP-res preparation
Scrapie strains 22L and ME7 were the kind gift of Dr. James Hope
(Veterinary Laboratories Agency, Surrey, UK) while the Obihiro scrapie
strain (Shinagawa et al., 1985) was the kind gift of Dr. Motohiro Horiuchi
(Hokkaido University, Sapporo, Japan). Tg(WT-E1) mice were from the
laboratory of Dr. David Harris (Washington University, St. Louis, Mo).
These mice express high levels of PrP-sen with an epitope tag (Bolton
et al., 1991) for the mouse monoclonal antibody 3F4 (PrP-sen3F4).
The mouse-adapted scrapie strains 22L, ME7, and Obihiro (Obi) in
DPBS were passaged once in Tg(WT-E1) mice (Chiesa et al., 1998) to
generate the brain homogenates 22L(3F4), ME7(3F4), and Obi(3F4). Tg
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designated as mock controls (Mock(3F4)). Brains from terminally ill Tg
(WT-E1) mice or mock-infected, age matched controls were harvested
and stored at −70 °C. To study the uptake of PrP-res from crude brain
homogenate, brains were dounce homogenized in DPBS (10% w/v),
sonicated, and then stored at −70 °C as described previously (Vorberg
et al., 2004a). Crude brain microsome fractions were prepared as
described in detail by Baron et al. (2002), while PrP-res was partially
puriﬁed as previously described (Raymond and Chabry, 2004) but
without proteinase K (PK) digestion. Partially puriﬁed PrP-res was
quantiﬁed bywestern blot using a standard protein concentration curve
derived from recombinant hamster PrP-sen. For experiments where
partially puriﬁed PrP-res preparations were compared to less puriﬁed
microsome or brain homogenate preparations, total protein content
was normalized using microsomes or brain homogenate from mock-
infected Tg(WT-E1) mice. Alexa-Fluor-596 labeled PrP-res preparations
were made as previously described by Magalhaes et al. (2005).
Cellular uptake of PrP-res
To analyze PrP-res uptake over time, experiments were performed
in 24 well microtiter plates as previously described (Vorberg et al.,
2004a). Brieﬂy, different cell numbers were initially plated in order to
ensure similar cell numbers at time of harvest. The number of cells
plated were: MoL42-CFD5 cells (0-24 h, 3×105 cells/ml; 48 h, 2×105
cells/ml; and 72 h, 1.5×105 cells/ml), CF10 and MoL42-ψ2A2 cells
(0–24 h, 4×105 cells/ml; 48 h, 2×105 cells/ml; and 72 h, 1.5×105 cells/
ml). After incubation at 37 °C for 24 h, the medium was removed and
replaced with 200 μl of brain homogenate, microsomes, or partially
puriﬁed PrP-res diluted in Opti-MEM. The cells were exposed to
equivalent amounts of PrP-res for each strain (10 ng for each
preparation). Mock preparations were diluted 1:10 in Opti-MEM.
Samples were then incubated at 37 °C for 2–4 h followed by the
addition of 400 μl/well of fresh media. At each time point, cells were
washed 4 times with 300 μl of fresh medium and either removed from
the plate using trypsin-EDTA (Invitrogen) and counted with a
hemacytometer or lysed directly in 3× lysis buffer (3 mM Tris–HCl, pH
7.4, 420 mM NaCl, 15 mM EDTA, 1.5% sodium deoxycholate, and 1.5%
Triton X-100). Lysates were treated with benzonase (0.167 U/μl)
(Novagen) for 30 min at 37 °C, then PK (60 μg/ml) (Roche) for 1 h at
37 °C followed by the addition of 1.2 μg of 4-(2-aminoethyl)
benzenesulfonylﬂuoride (PEFABLOC) (Roche). PK-digested lysates
were precipitated in four volumes of cold methanol for 2 h at
−20 °C followed by centrifugation at 20,800 ×g for 30 min. Pellets were
sonicated into sample buffer (2.5% SDS, 3 mM EDTA, 2% β-
mercaptoethanol, 5% glycerol, 0.02% bromphenol blue, and 63 mM
Tris–HCL, pH 6.8), boiled for 3 min, optionally PNGaseF treated for 12 h
according to the manufacturer's instructions (New England Biolabs),
and loaded on 16% Tris-glycine precast gels (Invitrogen). PrP was
detected by western blot analysis using the mouse monoclonal
antibody 3F4 (1:3,000) followed by secondary ECL-anti-mouse IgG
(1:5000) (Amersham) or anti-mouse IR-dye 800CW (1:10,000) (Li-Cor).
Quantitative ECL data was generated using the UN-SCAN-IT
software (Silk Scientiﬁc Corp.) according to the manufacturer's
instructions. In order to quantify the data within the linear range of
the ﬁlm, the ﬁrst three lanes of each gel were used as internal
standards to establish a constant ﬁlm exposure time which was
then used for every experiment. PrP-res levels were quantiﬁed from
gels exposed to ﬁlm for a set time (4 min) using a ﬁxed parameter
box (i.e. the box was the same volume for every experiment) and
the UN-SCAN-IT software. Pixel count totals within the ﬁxed
parameter box were summed and presented as pixels. When the
secondary antibody anti-mouse IR-dye 800CW was used to develop
the western blot, quantitative data were obtained using the Li-Cor
Odyssey IR scanner and the software provided with the system
(Li-Cor).To quantify the percentage of the input brain homogenate PrP-
res3F4 that was taken up by the cells, MoL42-CFD5 cells were plated
into 24 well plates as detailed above and scrapie-infected brain
homogenate containing 8 ng of PrP-res3F4 was added to the cells for 24
or 48 h. Following removal of the supernatant and four rinses of the
cells with PBBS, the cells were lysed and cell-associated PrP-res3F4 was
isolated as described above. For each strain, a standard curve
consisting of serial two-fold dilutions of the input PrP-res3F4 brain
homogenate was used to quantify the samples. These serial two-fold
dilutions (8 ng–1 ng) were loaded on every gel and used to establish a
standard curve to quantify only the samples run on the same gel. Two
experimentswere run for a total of 12 samples for each strain and time
point. Quantitative data were obtained using the Li-Cor Odyssey IR
scanner and the software provided with the system (Li-Cor).
Analysis of PrP-res uptake by ﬂuorescent microscopy
Cells were plated in Lab-Tek II chamber slides (8-well) (Nalge Nunc
Inc.) at the densities listed above. After 24 h at 37 °C, the media was
removed and immediately replaced with 200 μl of Opti-MEM containing
3 ng of partially puriﬁed PrP-res from 22L(3F4), ME7(3F4), or Obi(3F4) or
volume matched partially puriﬁed PrP-res Mock(3F4) preparations.
Following incubation from 2 to 48 h, the media was aspirated and the
cells were washed 4 times with fresh medium. 200 μl of 10%
formaldehyde was added to each well for 30 min, followed by 200 μl of
0.4% triton-X-100 for 10 min. The wells were then rinsed with 500 μl of
PBS (2×), and select chambers were treated with 200 μl of PK (10 μg/ml)
for 9min at 37 °C. The PKwas then removed and excess PK blockedwith
200 μl of PEFABLOC (10 mM). Wells were washed again with PBS and
treated with guanidine thiocyanate (4M, 200 μl/chamber) for 30 min at
25 °C. After rinsing in PBS, 200 μl of themouse 3F4monoclonal antibody
(1:200 dilution) was added for 30 min followed by PBS washes (3×) and
the addition of 200 μl of goat anti-mouse FITC conjugated antibody
(1:400dilution) for 30min. Following theantibody incubations, the slides
were rinsed in PBS and coverslip mounted with ProLong Gold antifade
reagent with DAPI (Invitrogen). Slides were viewed on an Olympus BX51
ﬂuorescent microscopewith both 20× and 40× air immersion objectives.
All images were taken with an Olympus DP71 camera and were
processed and analyzed with Microsuite Software (Olympus).
For comparison of PrP-res to Alexa-Fluor-596 conjugated PrP-res,
SN56 cells were plated in Lab-Tek II chamber slides (8-well) (Nalge
Nunc Inc.) at a 1:20 dilution from a conﬂuent 25 cm2 ﬂask and
differentiated with cAMP (1mm) in serum free Opti-MEM for 24 h. PrP-
res or Alexa-Fluor-596 conjugated PrP-res (8 ng) was added to the cells
and the cells were incubated for 24 h at 37 °C. Cells were then ﬁxed,
labeled and observed by ﬂorescent microscopy as described above.
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